News Roundup Price and market structure. XRP spent the week trading in the $1.10–$1.14 band, holding above the psychological $1 floor while repeatedly failing to escape its two-month range. The supportive undercurrents were real but modest: spot ETF products continued logging net inflows, and tokens kept leaving exchanges — a pattern typically read as accumulation rather than distribution. Neither force has been strong enough to overpower the broader downtrend that has held since the slide from May’s highs near $1.50. The CLARITY Act stalls out. Washington delivered the week’s most consequential story, and it wasn’t a good one for the bulls. The Digital Asset Market Clarity Act — the market-structure bill that would give XRP and the wider industry a durable statutory framework — missed its original July 4 signing target and is now grinding against an August 7 recess deadline. The merged Senate text released July 22 omitted the government-ethics provision Democrats had demanded, and Democratic opposition formed within hours of its release. By July 23, Majority Leader John Thune was publicly doubting a floor vote could happen before the summer break. Prediction markets told the story in miniature: Polymarket odds on 2026 passage swung from 24% up to 45% and back down to roughly 35% as the ethics impasse hardened. If the recess window closes, the bill’s realistic path shifts to the fall — a calendar dominated by midterm campaigning. Ripple’s corporate engine keeps running. Against the legislative gridlock, Ripple’s business development continued at pace. The company launched Ripple Mint, a unified platform for institutions to access, mint, redeem, and manage RLUSD; invested in compliance network Notabene to smooth RLUSD adoption by banks; secured full MiCA CASP authorization in Europe; partnered with SBI Group to bring RLUSD to Japan; and expanded its Bitso partnership for stablecoin settlement across Latin America. The bearish counterpoint deserves equal billing: RLUSD transfer volume fell roughly 26% over the period even as holder addresses grew — usage thinning while headcount rises. XRPL technical and on-chain. The ledger’s v3.2.0 release is live, though amendment activation continues to lag behind software availability as validators work through the voting process. Tokenized real-world assets on the XRPL reached approximately $4.38 billion by RWA.xyz’s count — but note a material data discrepancy: DeFiLlama’s methodology produces a far smaller figure. We flag the gap rather than pick a winner; readers citing XRPL RWA numbers should know the answer depends heavily on the tracker. Competition isn’t sleeping. Stellar posted genuine Q1 gains in payment volume and tokenized assets — real momentum in the same institutional corridors Ripple targets, and not something to wave away. Meanwhile, Japan remains the standout adoption story on Ripple’s side of the ledger, with regulated, consumer-facing products moving on the XRPL under full Financial Services Agency supervision. Forward-Look The following is informed analysis and speculation, not prediction. The near-term setup hinges on Washington, and the honest read is unfavorable: with the ethics dispute unresolved and floor time scarce, a pre-recess CLARITY vote looks unlikely, pushing the regulatory catalyst into an election-distorted autumn. Markets have partially priced this in — the Polymarket retreat from 45% suggests as much — but a formal punt to September could still pressure a token already stuck below its moving averages. The structural risk worth naming plainly is the price/utility disconnect. Ripple’s institutional wins increasingly route through RLUSD and fiat rails rather than XRP itself, meaning the company can succeed while the token stagnates. Multiple independent analysts have pressed this argument, Standard Chartered cut its XRP target from $8 to $2.80, and the recurring pattern of major Ripple announcements followed by price declines suggests the market is already discounting deal headlines that don’t create token demand. The counter-case: exchange outflows and steady ETF inflows show patient capital accumulating; MiCA opens Europe at full scale; Japan’s regulated adoption compounds quietly; and a statute — whenever it finally lands — remains the single biggest durable unlock for U.S. institutional participation. The question is timing, and timing just got longer.